Investigation of varicella-zoster vaccine immunogenicity according to frailty status
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0009555
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
?Adults aged 65 and older scheduled to receive the recombinant zoster vaccine (Recombinant Zoster Vaccine, RZV) at Bundang Seoul National University Hospital.
?For 100 individuals, screening will be conducted using the K-FRAIL tool, with plans to enroll 40 in the robust group, 40 in the pre-frail group, and 20 in the frail group.
?Individuals with immunosuppression (e.g., undergoing cancer treatment within the past 5 years, taking immunosuppressive drugs, or having autoimmune diseases)
?Individuals who have received another vaccination within the past 2 weeks
?Individuals who have had a shingles infection within the past year
?Individuals who have received the Zostavax vaccine within the past year
?Individuals who do not consent to participate in this study and the follow-up study
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method